Treatment Patterns of Biologic Disease-Modifying Antirheumatic Drugs and Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis in Japan: A Claims-Based Cohort Study

• Main Authors: Masahiko Miyashiro (Author), Teita Asano (Author), Yutaka Ishii (Author), Celine Miyazaki (Author), Hirohito Shimizu (Author), Junya Masuda (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Reports on treatment patterns of biologic disease-modifying antirheumatic drugs (bDMARDs)/Janus kinase inhibitors (JAKi) for rheumatoid arthritis (RA) in clinical practice are still sparse in Japan, especially in combination with conventional synthetic DMARDs (csDMARDs). Objectiv...